Type-2-diabetes: Therapy of hospitalized patients

被引：0
|
作者：
Kellerer, Monika [1 ]
机构：
[1] Marien Hosp Stuttgart, Stuttgart, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2008年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [41] Amyloid Formation in Type-2-Diabetes
    不详
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (08) : 442 - 442
  • [42] Early detection of Type-2-Diabetes
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156
  • [43] Customized treatment of Type-2-Diabetes
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (05): : 277 - 278
  • [44] News about Type-2-Diabetes
    Mehnert, Hellmut
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (02) : 149 - 150
  • [45] Type-2-diabetes in children and adolescents
    Holl, RW
    Wabitsch, M
    Heinze, E
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2001, 149 (07) : 660 - 669
  • [46] Effectiveness of the incretin therapy in type-2-Diabetes - A meta-analysis
    Rose, B.
    [J]. DIABETOLOGE, 2008, 4 (02): : 125 - 126
  • [47] Insulin Therapy in Type-1 and Type-2-Diabetes: Identify patients' needs and take them seriously
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (03): : 8 - 9
  • [48] Role of incretin-based therapy in hospitalized patients with type 2 diabetes
    Edgar Gracia-Ramos, Abraham
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (02) : 508 - 509
  • [49] SGLT2-Inhibitors - A Milestone in the Treatment of Patients with Type-2-Diabetes
    Preisker, S.
    [J]. NEPHROLOGE, 2020, 15 (06): : 368 - 371
  • [50] Drug Therapy in multimorbid Type-2-Diabetes Patients Analysis of a German insurance Claims Data Set
    Wilke, T.
    Hahn, P.
    Groth, A.
    Fuchs, A.
    Maywald, U.
    [J]. DIABETOLOGE, 2017, 13 (02): : 108 - 114
12345